Published in Int J Cancer on June 15, 1974
Continuous lymphoid cell lines with characteristics of B cells (bone-marrow-derived), lacking the Epstein-Barr virus genome and derived from three human lymphomas. Proc Natl Acad Sci U S A (1974) 5.13
Cytotoxic effector cells specific for B Cell lines transformed by Epstein-Barr virus are present in patients with infectious mononucleosis. Proc Natl Acad Sci U S A (1975) 4.21
Lysozyme synthesis by established human and murine histiocytic lymphoma cell lines. J Exp Med (1976) 3.49
Nucleosomal structure of Epstein-Barr virus DNA in transformed cell lines. J Virol (1979) 1.91
Products of vitamin D3 or 7-dehydrocholesterol metabolism by cytochrome P450scc show anti-leukemia effects, having low or absent calcemic activity. PLoS One (2010) 1.83
Lymphoblastoid cell lines from patients with chronic lymphocytic leukemia: identification of tumor origin by idiotypic analysis. Proc Natl Acad Sci U S A (1978) 1.78
Presence of Epstein-Barr virus receptors, but absence of virus penetration, in cells of an Epstein-Barr virus genome-negative human lymphoblastoid T line (Molt 4). J Virol (1977) 1.44
Human immunoglobulin kappa light chain genes of subgroups II and III. Nucleic Acids Res (1985) 1.37
An Epstein-Barr virus immortalization associated gene segment interferes specifically with the IFN-induced anti-proliferative response in human B-lymphoid cell lines. EMBO J (1990) 1.18
Surface receptors on human haematopoietic cell lines. Clin Exp Immunol (1976) 0.95
Mumps virus replication in human lymphoid cell lines and in peripheral blood lymphocytes: preference for T cells. Infect Immun (1982) 0.88
A sensitive high-throughput assay for evaluating host-pathogen interactions in Cryptococcus neoformans infection. PLoS One (2011) 0.81
Herpesvirus-lymphoid cell interactions: comparative studies on the biology of herpes simplex virus-induced Fc receptors in B, T, and "null" lymphoid cell lines. J Virol (1980) 0.80
Cell cycle-specific expression and nuclear binding of DNA polymerase alpha. Mol Cell Biol (1991) 0.76
Effects of the ACTH(4-9) analogue, ORG 2766, on vincristine cytotoxicity in two human lymphoma cell lines, U937 and U715. Br J Cancer (1994) 0.75
Plateau distributions of DNA fragment lengths produced by extended light exposure of extranuclear photosensitizers in human cells. Nucleic Acids Res (1992) 0.75
Establishment and characterization of a human histiocytic lymphoma cell line (U-937). Int J Cancer (1976) 14.08
Continuous lymphoid cell lines with characteristics of B cells (bone-marrow-derived), lacking the Epstein-Barr virus genome and derived from three human lymphomas. Proc Natl Acad Sci U S A (1974) 5.13
Characteristic chromosomal abnormalities in biopsies and lymphoid-cell lines from patients with Burkitt and non-Burkitt lymphomas. Int J Cancer (1976) 4.35
The orphan receptor GPR55 is a novel cannabinoid receptor. Br J Pharmacol (2007) 4.22
A massive binary black-hole system in OJ 287 and a test of general relativity. Nature (2008) 3.50
Lysozyme synthesis by established human and murine histiocytic lymphoma cell lines. J Exp Med (1976) 3.49
Fasting capillary glucose as a screening test for gestational diabetes mellitus. BJOG (2006) 3.23
Established immunoglobulin producing myeloma (IgE) and lymphoblastoid (IgG) cell lines from an IgE myeloma patient. Clin Exp Immunol (1970) 3.17
A primordial tRNA modification required for the evolution of life? EMBO J (2001) 3.01
The establishment of lymphoblastoid lines from adult and fetal human lymphoid tissue and its dependence on EBV. Int J Cancer (1971) 2.96
K562--a human erythroleukemic cell line. Int J Cancer (1979) 2.84
Phenotypic and cytogenetic characteristics of human B-lymphoid cell lines and their relevance for the etiology of Burkitt's lymphoma. Adv Cancer Res (1982) 2.68
Haematopoietic malignancies in rheumatoid arthritis: lymphoma risk and characteristics after exposure to tumour necrosis factor antagonists. Ann Rheum Dis (2005) 2.43
High frequency of multiple melanomas and breast and pancreas carcinomas in CDKN2A mutation-positive melanoma families. J Natl Cancer Inst (2000) 2.41
Classification and biological nature of established human hematopoietic cell lines. Int J Cancer (1975) 2.16
Susceptibility to infection by the human immunodeficiency virus (HIV) correlates with T4 expression in a parental monocytoid cell line and its subclones. Virology (1987) 2.11
Phorbol ester-induced differentiation of chronic lymphocytic leukaemia cells. Nature (1980) 2.08
High-frequency establishment of human immunoglobulin-producing lymphoblastoid lines from normal and malignant lymphoid tissue and peripheral blood. Int J Cancer (1971) 2.06
MEC1 and MEC2: two new cell lines derived from B-chronic lymphocytic leukaemia in prolymphocytoid transformation. Leuk Res (1999) 1.90
Tumorigenicity of human hematopoietic cell lines in athymic nude mice. Int J Cancer (1977) 1.84
Phenotypic characterization of synovial tissue cells in situ in different types of synovitis. Arthritis Rheum (1983) 1.78
Nasal continuous positive airway pressure: experiences with a new technical approach. Acta Paediatr (1993) 1.74
Transfer RNA modification: influence on translational frameshifting and metabolism. FEBS Lett (1999) 1.73
Phenotypic characterization of the human mast-cell line HMC-1. Scand J Immunol (1994) 1.73
Expression of mad, mxi1, max and c-myc during induced differentiation of hematopoietic cells: opposite regulation of mad and c-myc. Oncogene (1994) 1.69
Radio imaging of the very-high-energy gamma-ray emission region in the central engine of a radio galaxy. Science (2009) 1.66
Very-high-energy gamma rays from a distant quasar: how transparent is the universe? Science (2008) 1.65
Production of beta 2-microglobulin by normal and malignant human cell lines and peripheral lymphocytes. Transplant Rev (1974) 1.57
The G(-248)A polymorphism in the promoter region of the Bax gene does not correlate with prognostic markers or overall survival in chronic lymphocytic leukemia. Leukemia (2006) 1.47
Effects of exogenous stress protein 70 on the functional properties of human promonocytes through binding to cell surface and internalization. Cell Stress Chaperones (1998) 1.45
Characteristics of Epstein-Barr virus activation of human B lymphocytes. J Exp Med (1981) 1.43
Natural killer cells kill tumour cells at a given stage of differentiation. Nature (1981) 1.43
Surface characteristics of the U-937 human histiocytic lymphoma cell line: specific changes during inducible morphologic and functional differentiation in vitro. Haematol Blood Transfus (1981) 1.42
Interleukin-2 and a T cell hybridoma (MP6) derived B cell-stimulatory factor act synergistically to induce proliferation and differentiation of human B-chronic lymphocytic leukemia cells. Leukemia (1989) 1.42
Variable very-high-energy gamma-ray emission from the microquasar LS I +61 303. Science (2006) 1.40
Summary report on the ISOBM TD-4 Workshop: analysis of 56 monoclonal antibodies against the MUC1 mucin. San Diego, Calif., November 17-23, 1996. Tumour Biol (1998) 1.40
A novel mutation in the beta-protein coding region of the amyloid beta-protein precursor (APP) gene. Hum Genet (1992) 1.39
C3a and C5a are chemotaxins for human mast cells and act through distinct receptors via a pertussis toxin-sensitive signal transduction pathway. J Immunol (1996) 1.37
Induction of differentiation of the human histiocytic lymphoma cell line U-937 by 1 alpha,25-dihydroxycholecalciferol. Cancer Res (1983) 1.37
Formation and growth of multicellular spheroids of human origin. Int J Cancer (1983) 1.35
In vitro maturation of mononuclear phagocytes and susceptibility to HIV-1 infection. J Acquir Immune Defic Syndr (1991) 1.34
Phenotypic changes of human neuroblastoma cells in culture induced by 12-O-tetradecanoyl-phorbol-13-acetate. Int J Cancer (1981) 1.33
Gene expression profiling of isolated tumour cells from anaplastic large cell lymphomas: insights into its cellular origin, pathogenesis and relation to Hodgkin lymphoma. Leukemia (2009) 1.33
Functional and morphological characterization of cultures of Kupffer cells and liver endothelial cells prepared by means of density separation in Percoll, and selective substrate adherence. Cell Tissue Res (1985) 1.31
Stem cell factor is a chemotactic factor for human mast cells. J Immunol (1994) 1.29
Immune functions of human synovial cells. Phenotypic and T cell regulatory properties of macrophage-like cells that express HLA-DR. Arthritis Rheum (1982) 1.29
Entrapment of animal cells for production of monoclonal antibodies and other biomolecules. Nature (1983) 1.29
Circular chromosomal map of a temperate Bacillus phage. Virology (1967) 1.28
Expression and function of chemokine receptors in human multiple myeloma. Leukemia (2003) 1.26
Human cell lines U-937, THP-1 and Mono Mac 6 represent relatively immature cells of the monocyte-macrophage cell lineage. Leukemia (1994) 1.25
450K-array analysis of chronic lymphocytic leukemia cells reveals global DNA methylation to be relatively stable over time and similar in resting and proliferative compartments. Leukemia (2012) 1.23
Expression of the bcl-2 gene in human multiple myeloma cell lines and normal plasma cells. Blood (1992) 1.23
Physiology of canine intraventricular conduction and endocardial excitation. Circ Res (1972) 1.22
Independent expression of the two HL-A antigen polypeptide chains. Eur J Immunol (1976) 1.22
Insulin-like growth factor I is a growth and survival factor in human multiple myeloma cell lines. Blood (1996) 1.21
Identification of a cell-surface glycoprotein mediating cell adhesion in EBV-immortalized normal B cells. Int J Cancer (1986) 1.19
Platelet activation by Shiga toxin and circulatory factors as a pathogenetic mechanism in the hemolytic uremic syndrome. Blood (2001) 1.19
Bead-to-bead transfer of Chinese hamster ovary cells using macroporous microcarriers. Cytotechnology (1994) 1.18
Beta 2-microglobulin in chronic lymphocytic leukaemia. Scand J Haematol (1980) 1.18
Surface glycoprotein patterns of normal and malignant human lymphoid cells. II. B cells, B blasts and Epstein-Barr virus (EBV)-positive and -negative B lymphoid cell lines. Int J Cancer (1977) 1.18
Beta 2-microglobulin production in vitro by human hematopoietic, mesenchymal, and epithelial cells. J Immunol (1974) 1.17
Clonal evolution as judged by immunoglobulin heavy chain gene rearrangements in relapsing precursor-B acute lymphoblastic leukemia. Eur J Haematol (1999) 1.17
Inactivation of tumor suppressor genes, p53 and Rb1, in plasma cell dyscrasias. Leukemia (1994) 1.16
Accessory function of human tumor cell lines. I. Production of interleukin 1 by the human histiocytic lymphoma cell line U-937. Eur J Immunol (1982) 1.15
Establishment and characterization of cell lines from human small cell and large cell carcinomas of the lung. Acta Pathol Microbiol Immunol Scand A (1985) 1.14
Development of immunocytes and immunoglobulin production in long-term cultures from normal and malignant human lymph nodes. Int J Cancer (1968) 1.14
Myeloperoxidase mediates cell adhesion via the alpha M beta 2 integrin (Mac-1, CD11b/CD18). J Cell Sci (1997) 1.13
Phorbol ester-induced terminal differentiation is inhibited in human U-937 monoblastic cells expressing a v-myc oncogene. Proc Natl Acad Sci U S A (1988) 1.12
Growth- and differentiation-associated expression of bcl-2 in B-chronic lymphocytic leukemia cells. Blood (1992) 1.11
Epstein-Barr virus (EBV) can immortalize B-cll cells activated by cytokines. Leukemia (1994) 1.11
Characteristics of established myeloma and lymphoblastoid cell lines derived from an E myeloma patient: a comparative study. Int J Cancer (1971) 1.11
Consumption of refined sugar by patients with Crohn's disease, ulcerative colitis, or irritable bowel syndrome. Scand J Gastroenterol (1983) 1.10
A new device for administration of nasal continuous positive airway pressure in the newborn: an experimental study. Crit Care Med (1988) 1.10
Myeloperoxidase in human lung lavage. I. A marker of local neutrophil activity. Inflammation (1990) 1.09
Differential expression of platelet-derived growth factor and transforming growth factor genes in small- and non-small-cell human lung carcinoma lines. Int J Cancer (1988) 1.08
Neurone specific enolase: a useful diagnostic serum marker for small cell carcinoma of the lung. Thorax (1985) 1.08
Expression of gamma-subunit of enolase, neuron-specific enolase, in human non-neuroendocrine tumors and derived cell lines. Lab Invest (1986) 1.07
Increase in neuropsychiatric symptoms after occupational exposure to low levels of styrene. Br J Ind Med (1993) 1.07
Expression of intermediate filaments in established human lung cancer cell lines. An indicator of differentiation and derivation. Lab Invest (1984) 1.07
Measurement of skin temperature and heat flow from skin in term newborn babies. Acta Paediatr (1995) 1.06
Drastically increased expression of MYC and FOS protooncogenes during in vitro differentiation of chronic lymphocytic leukemia cells. Proc Natl Acad Sci U S A (1987) 1.06
Functional antagonism between vitamin D3 and retinoic acid in the regulation of CD14 and CD23 expression during monocytic differentiation of U-937 cells. J Immunol (1993) 1.06
Paraffin section storage and immunohistochemistry. Effects of time, temperature, fixation, and retrieval protocol with emphasis on p53 protein and MIB1 antigen. Appl Immunohistochem Mol Morphol (2000) 1.06
Surface glycoprotein patterns of normal and malignant human lymphoid cells. I. T cells T blasts and leukemic T cell lines. Int J Cancer (1977) 1.05
Prognostic significance of flow cytometry studies in B-cell non-Hodgkin lymphoma. Hematol Oncol (1990) 1.05
Lymphoma incidence in a Swedish county during 1969-1987. Acta Oncol (1992) 1.05
Identification of cell surface immunoglobulin markers by protein A-containing fluorescent staphylococci. Scand J Immunol (1974) 1.04
Detection of tumor-specific cytotoxic drug activity in vitro using the fluorometric microculture cytotoxicity assay and primary cultures of tumor cells from patients. Int J Cancer (1994) 1.04
Immunocytochemical demonstration of neuron-specific enolase (NSE) in human lung cancers. Am J Clin Pathol (1985) 1.04
Inverse relation between vitamin D and serum total immunoglobulin G in the Scandinavian Cystic Fibrosis Nutritional Study. Eur J Clin Nutr (2010) 1.04